<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.3.1" -->
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>
<channel>
	<title>Comments on: FDA&#8217;s Richard Pazdur Cares Little for the Scientific Process and the Needs of Desperate Patients</title>
	<link>http://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the-needs-of-desperate-patients/</link>
	<description>CareToLive &#124; Help Men With Late Stage Prostate Cancer &#124; Provenge Now!</description>
	<pubDate>Tue, 06 Jan 2009 12:31:21 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.3.1</generator>
		<item>
		<title>By: men with breast cancer</title>
		<link>http://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the-needs-of-desperate-patients/#comment-2797</link>
		<dc:creator>men with breast cancer</dc:creator>
		<pubDate>Wed, 16 Jul 2008 02:49:31 +0000</pubDate>
		<guid>http://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the-needs-of-desperate-patients/#comment-2797</guid>
		<description>[...] con the public again. Where are most of the advocacy groups ... busy raking in the dough withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the...Breast cancer in men : CancerbackupThis section is about breast cancer in men. It describes what it [...]</description>
		<content:encoded><![CDATA[<p>[&#8230;] con the public again. Where are most of the advocacy groups &#8230; busy raking in the dough <a href="withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the...Breast" rel="nofollow">withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the&#8230;Breast</a> cancer in men : CancerbackupThis section is about breast cancer in men. It describes what it [&#8230;]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: men of business</title>
		<link>http://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the-needs-of-desperate-patients/#comment-2133</link>
		<dc:creator>men of business</dc:creator>
		<pubDate>Wed, 25 Jun 2008 17:04:26 +0000</pubDate>
		<guid>http://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the-needs-of-desperate-patients/#comment-2133</guid>
		<description>[...] con the public again. Where are most of the advocacy groups ... busy raking in the dough withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the...Men's Suits - Business SuitsMen's Suits Custom Made Within One Week. business Suits For men Shipped [...]</description>
		<content:encoded><![CDATA[<p>[&#8230;] con the public again. Where are most of the advocacy groups &#8230; busy raking in the dough <a href="withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the...Men" rel="nofollow">withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the&#8230;Men</a>&#8217;s Suits - Business SuitsMen&#8217;s Suits Custom Made Within One Week. business Suits For men Shipped [&#8230;]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: patient advocacy</title>
		<link>http://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the-needs-of-desperate-patients/#comment-1988</link>
		<dc:creator>patient advocacy</dc:creator>
		<pubDate>Fri, 20 Jun 2008 21:43:44 +0000</pubDate>
		<guid>http://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the-needs-of-desperate-patients/#comment-1988</guid>
		<description>[...] con the public again. Where are most of the advocacy groups ... busy raking in the dough withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the...National Alliance of Methadone AdvocatesThe primary objective of NAMA is to advocate for the patient [...]</description>
		<content:encoded><![CDATA[<p>[&#8230;] con the public again. Where are most of the advocacy groups &#8230; busy raking in the dough <a href="withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the...National" rel="nofollow">withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the&#8230;National</a> Alliance of Methadone AdvocatesThe primary objective of NAMA is to advocate for the patient [&#8230;]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: business science</title>
		<link>http://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the-needs-of-desperate-patients/#comment-1702</link>
		<dc:creator>business science</dc:creator>
		<pubDate>Wed, 11 Jun 2008 09:00:50 +0000</pubDate>
		<guid>http://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the-needs-of-desperate-patients/#comment-1702</guid>
		<description>[...] con the public again. Where are most of the advocacy groups ... busy raking in the dough withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the...Science/AAAS Collections: Science and BusinessSmall business Looms Large: Jeffrey Mervis science 25 [...]</description>
		<content:encoded><![CDATA[<p>[&#8230;] con the public again. Where are most of the advocacy groups &#8230; busy raking in the dough <a href="withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the...Science/AAAS" rel="nofollow">withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the&#8230;Science/AAAS</a> Collections: Science and BusinessSmall business Looms Large: Jeffrey Mervis science 25 [&#8230;]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: stages of cancer</title>
		<link>http://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the-needs-of-desperate-patients/#comment-1698</link>
		<dc:creator>stages of cancer</dc:creator>
		<pubDate>Wed, 11 Jun 2008 00:38:04 +0000</pubDate>
		<guid>http://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the-needs-of-desperate-patients/#comment-1698</guid>
		<description>[...] con the public again. Where are most of the advocacy groups ... busy raking in the dough withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the...Special Health Modules: What are the stages that cancer survivors ...Since then, others also have [...]</description>
		<content:encoded><![CDATA[<p>[&#8230;] con the public again. Where are most of the advocacy groups &#8230; busy raking in the dough <a href="withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the...Special" rel="nofollow">withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the&#8230;Special</a> Health Modules: What are the stages that cancer survivors &#8230;Since then, others also have [&#8230;]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: shelf rx</title>
		<link>http://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the-needs-of-desperate-patients/#comment-1337</link>
		<dc:creator>shelf rx</dc:creator>
		<pubDate>Mon, 02 Jun 2008 17:30:50 +0000</pubDate>
		<guid>http://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the-needs-of-desperate-patients/#comment-1337</guid>
		<description>[...] con the public again. Where are most of the advocacy groups ... busy raking in the dough withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the...Rx for a category: by squeezing the health angle, shelf-stable ...Rx for a category: by squeezing [...]</description>
		<content:encoded><![CDATA[<p>[&#8230;] con the public again. Where are most of the advocacy groups &#8230; busy raking in the dough <a href="withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the...Rx" rel="nofollow">withouthttp://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the&#8230;Rx</a> for a category: by squeezing the health angle, shelf-stable &#8230;Rx for a category: by squeezing [&#8230;]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: FDA’s Richard Pazdur Cares Little for the Scientific Process and the Needs of Desperate Patients &#183; Prostate Cancer</title>
		<link>http://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the-needs-of-desperate-patients/#comment-1109</link>
		<dc:creator>FDA’s Richard Pazdur Cares Little for the Scientific Process and the Needs of Desperate Patients &#183; Prostate Cancer</dc:creator>
		<pubDate>Wed, 28 May 2008 11:36:11 +0000</pubDate>
		<guid>http://caretolive.com/2008-05-28/fdas-richard-pazdur-cares-little-for-the-scientific-process-and-the-needs-of-desperate-patients/#comment-1109</guid>
		<description>[...] prostate cancer blog wrote an interesting post today onHere&#8217;s a quick excerpt There was ample of evidence of survival benefit conferred by Provenge as a treatment in contrast to Dr. Pazdur’s statement: “Believe me, if there were a clear survival effect, the drug would be approved,”. In fact, Dr. Pazdur’s focus on the statistical flaws showed that the main problem in the FDA drug approval process as practiced by Dr. Pazdur is a slavish following of rigid statistical rules without properly factoring in clinical knowledge required to give meaning to such numerical data. Th [...]</description>
		<content:encoded><![CDATA[<p>[&#8230;] prostate cancer blog wrote an interesting post today onHere&#8217;s a quick excerpt There was ample of evidence of survival benefit conferred by Provenge as a treatment in contrast to Dr. Pazdur’s statement: “Believe me, if there were a clear survival effect, the drug would be approved,”. In fact, Dr. Pazdur’s focus on the statistical flaws showed that the main problem in the FDA drug approval process as practiced by Dr. Pazdur is a slavish following of rigid statistical rules without properly factoring in clinical knowledge required to give meaning to such numerical data. Th [&#8230;]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
